By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Domainex Ltd 

324 Cambridge Science Park

Cambridge    CB4 0WG  United Kingdom
Phone: 44-0-1993-201801 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Domainex Ltd Launches New BioassayBuilder Service To Strengthen Its Drug Discovery Platform 7/1/2015 9:45:29 AM
Domainex Ltd Announces The Grant Of US And European Patents For Its Lead Programme, Targeting IKK Epsilon And TBK1 For The Treatment Of Diseases Such As COPD And Psoriasis 5/11/2015 9:55:28 AM
Domainex Ltd Prepares For Expansion As It Announces The Appointment Of Barry Knight As Chief Financial Officer And Company Secretary, And Thomas Mander As Chief Operating Officer 4/8/2015 9:48:50 AM
ZoBio And Domainex Ltd Join Forces To Deliver Crucial Drug Target Information To Support FORMA Therapeutics, Inc.’ Drug Discovery Programs 12/8/2014 10:15:00 AM
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014 10:30:11 AM
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014 3:06:27 PM
University of Warwick Wins Domainex Ltd's First Discovery STAR Award to Support Hunt for New Chagas Disease Treatment 9/3/2013 8:54:08 AM
Domainex Ltd Announces Investment Round to Progress Its TBK1/IKKe and Epigenetic Programs 2/14/2013 10:21:02 AM
Domainex Ltd Launches Discovery STAR Award to Support Early Academic Drug Discovery 1/22/2013 11:10:06 AM
Domainex Ltd Researchers Identify Small-Molecule Inhibitors of TBK1/IKKepsilon Affecting IL-17 Signaling 11/5/2012 12:01:39 PM
123
//-->